|
1
|
Hall MC, Womack S, Sagalowsky AI, Carmody
T, Erickstad MD and Roehrborn CG: Prognostic factors, recurrence
and survival in transitional cell carcinoma of the upper urinary
tract: A 30-year experience in 252 patients. Urology. 52:594–601.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Munoz JJ and Ellison LM: Upper tract
urothelial neoplasms: Incidence and survival during the last 2
decades. J Urol. 164:1523–1525. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rouprêt M, Zigeuner R, Palou J, Boehle A,
Kaasinen E, Sylvester R, Babjuk M and Oosterlinck W: European
guidelines for the diagnosis and management of upper urinary tract
urothelial cell carcinomas: 2011 update. Eur Urol. 59:584–594.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Krabbe LM, Lotan Y, Bagrodia A, Gayed BA,
Darwish OM, Youssef RF, Bolenz C, Sagalowsky AI, Raj GV, Shariat
SF, et al: Prospective comparison of molecular signatures in
urothelial cancer of the bladder and the upper urinary tract is
there evidence for discordant biology? J Urol. 191:926–931. 2014.
View Article : Google Scholar
|
|
5
|
Hautmann RE, de Petriconi RC, Pfeiffer C
and Volkmer BG: Radical cystectomy for urothelial carcinoma of the
bladder without neoadjuvant or adjuvant therapy: Long term results
in 1100 patients. Eur Urol. 61:1039–1047. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Margulis V, Shariat SF, Matin SF, Kamat
AM, Zigeuner R, Kikuchi E, Lotan Y, Weizer A and Raman JD; The
Upper Tract Urothelial Carcinoma Collaboration: Outcomes of radical
nephroureterectomy: A series from the upper tract urothelial
carcinoma collaboration. Cancer. 115:1224–1233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: microRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Visone R and Croce CM: MiRNAs and cancer.
Am J Pathol. 174:1131–1138. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Croce CM: Causes and consequences of
microRNA dysregu lation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar
|
|
12
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K,
Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs
in serum: A novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang X, Liang M, Dittmar R and Wang L:
Extracellular microRNAs in urologic malignancies: Chances and
challenges. Int J Mol Sci. 14:14785–14799. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Izquierdo L, Ingelmo Torres M, Mallofré C,
Lozano JJ, Verhasselt Crinquette M, Leroy X, Colin P, Comperat E,
Roupret M, Alcaraz A and Mengual L: Prognostic value of microRNA
expression pattern in upper tract urothelial carcinoma. BJU Int.
113:813–821. 2014. View Article : Google Scholar
|
|
15
|
Liu R, Zhang C, Hu Z, Li G, Wang C, Yang
C, Huang D, Chen X, Zhang H, Zhuang R, et al: A five-microRNA
signature identified from genome-wide serum microRNA expression
profiling serves as a fingerprint for gastric cancer diagnosis. Eur
J Cancer. 47:784–791. 2011. View Article : Google Scholar
|
|
16
|
Yu S, Liu Y, Wang J, Guo Z, Zhang Q, Yu F,
Zhang Y, Huang K, Li Y, Song E, et al: Circulating microRNA
profiles as potential biomarkers for diagnosis of papillary thyroid
carcinoma. J Clin Endocrinol Metab. 97:2084–2092. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY,
Zhang JF, Shen HB, Zhang CY and Zen K: Serum microRNA profiles
serve as novel biomarkers for HBV infection and diagnosis of HBV
positive hepatocarcinoma. Cancer Res. 70:9798–9807. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang C, Wang C, Chen X, Chen S, Zhang Y,
Zhi F, Wang J, Li L, Zhou X, Li N, et al: Identification of seven
serum microRNAs from a genome-wide serum microRNA expression
profile as potential noninvasive biomarkers for malignant
astrocytomas. Int J Cancer. 132:116–127. 2013. View Article : Google Scholar
|
|
19
|
Sauter G, Algaba F, Amin M, et al: Tumours
of the urinary system: Non-invasive urothelial neoplasia. Eble JN,
Sauter G, Epstein JI and Sesterhenn IA: The WHO Classification of
Tumours of the Urinary System and Male Genital Organs. IARC Press;
Lyon: pp. 110–114. 2004
|
|
20
|
Sobin DH and Witteking CH: TNM
Classification of Malignant Tumours. 6th edition. Wiley-Liss; New
York, NY: pp. 199–202. 2002
|
|
21
|
Sanders I, Holdenrieder S,
Walgenbach-Brunagel G, Walgenbach-Brünagel G, von Ruecker A,
Kristiansen G, Müller SC and Ellinger J: Evaluation of reference
genes for the analysis of serum miRNA in patients with prostate
cancer, bladder cancer and renal cell carcinoma. Int J Urol.
19:1017–1025. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cortez MA, Bueso Ramos C, Ferdin J,
Lopez-Berestein G, Sood AK and Calin GA: MicroRNAs in body
fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol.
8:467–477. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zen K and Zhang CY: Circulating microRNAs:
A novel class of biomarkers to diagnose and monitor human cancers.
Med Res Rev. 32:326–348. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brosnan JA and Iacobuzio Donahue CA: A new
branch on the tree: Next-generation sequencing in the study of
cancer evolution. Semin Cell Dev Biol. 23:237–242. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pritchard CC, Cheng HH and Tewari M:
MicroRNA profiling: Approaches and considerations. Nat Rev Genet.
13:358–369. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mlcochova H, Hezova R, Stanik M and Slaby
O: Urine microRNAs as potential noninvasive biomarkers in urologic
cancers. Urol Oncol. 32:41 e41–e49. 2014. View Article : Google Scholar
|
|
27
|
Mengual L, Lozano JJ, Ingelmo-Torres M,
Gazquez C, Ribal MJ and Alcaraz A: Using microRNA profiling in
urine samples to develop a non-invasive test for bladder cancer.
Int J Cancer. 133:2631–2641. 2013.PubMed/NCBI
|
|
28
|
Adam L, Wszolek MF, Liu CG, Jing W, Diao
L, Zien A, Zhang JD, Jackson D and Dinney CP: Plasma microRNA
profiles for bladder cancer detection. Urol Oncol. 31:1701–1708.
2013. View Article : Google Scholar
|
|
29
|
Cookson VJ, Bentley MA, Hogan BV, Horgan
K, Hayward BE, Hazelwood LD and Hughes TA: Circulating microRNA
profiles reflect the presence of breast tumours but not the
profiles of microRNAs within the tumours. Cell Oncol (Dordr).
35:301–308. 2012. View Article : Google Scholar
|
|
30
|
Chung YW, Bae HS, Song JY, Lee JK, Lee NW,
Kim T and Lee KW: Detection of microRNA as novel biomarkers of
epithelial ovarian cancer from the serum of ovarian cancer
patients. Int J Gynecol Cancer. 23:673–679. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tanaka K, Miyata H, Yamasaki M, Sugimura
K, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M and
Doki Y: Circulating miR-200c levels significantly predict response
to chemotherapy and prognosis of patients undergoing neoadjuvant
chemotherapy for esophageal cancer. Ann Surg Oncol. 20(Suppl 3):
S607–S615. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang HY, Yan LX, Shao Q, Fu S, Zhang ZC,
Ye W, Zeng YX and Shao JY: Profiling plasma microRNA in
nasopharyngeal carcinoma with deep sequencing. Clin Chem.
60:773–782. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kannan M, Mohan KV, Kulkarni S and Atreya
C: Membrane array-based differential profiling of platelets during
storage for 52 miRNAs associated with apoptosis. Transfusion.
49:1443–1450. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang C, Wang C, Chen X, Yang C, Li K,
Wang J, Dai J, Hu Z, Zhou X, Chen L, et al: Expression profile of
microRNAs in serum: A fingerprint for esophageal squamous cell
carcinoma. Clin Chem. 56:1871–1879. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lionetti M, Musto P, Di Martino MT, Fabris
S, Agnelli L, Todoerti K, Tuana G, Mosca L, Gallo Cantafio ME,
Grieco V, et al: Biological and clinical relevance of miRNA
expression signatures in primary plasma cell leukemia. Clin Cancer
Res. 19:3130–3142. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kanaan Z, Roberts H, Eichenberger MR,
Billeter A, Ocheretner G, Pan J, Rai SN, Jorden J, Williford A and
Galandiuk S: A plasma microRNA panel for detection of colorectal
adenomas: A step toward more precise screening for colorectal
cancer. Ann Surg. 258:400–408. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zheng G, Wang H, Zhang X, Yang Y, Wang L,
Du L, Li W, Li J, Qu A, Liu Y and Wang C: Identification and
validation of reference genes for qPCR detection of serum microRNAs
in colorectal adenocarcinoma patients. PLoS One. 8:e830252013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang Y, Gu J, Roth JA, Hildebrandt MA,
Lippman SM, Ye Y, Minna JD and Wu X: Pathway-based serum microRNA
profiling and survival in patients with advanced stage non-small
cell lung cancer. Cancer Res. 73:4801–4809. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu C, Iqbal J, Teruya-Feldstein J, Shen
Y, Dabrowska MJ, Dybkaer K, Lim MS, Piva R, Barreca A, Pellegrino
E, et al: MicroRNA expression profiling identifies molecular
signatures associated with anaplastic large cell lymphoma. Blood.
122:2083–2092. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mahn R, Heukamp LC, Rogenhofer S, von
Ruecker A, Müller SC and Ellinger J: Circulating microRNAs (miRNA)
in serum of patients with prostate cancer. Urology. 77:1265e9–e16.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hauser S, Wulfken LM, Holdenrieder S,
Moritz R, Ohlmann CH, Jung V, Becker F, Herrmann E,
Walgenbach-Brünagel G, von Ruecker A, et al: Analysis of serum
microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378)
as potential biomarkers in renal cell carcinoma. Cancer Epidemiol.
36:391–394. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang Z, Furge KA, Yang XJ, Teh BT and
Hansel DE: Comparative gene expression profiling analysis of
urothelial carcinoma of the renal pelvis and bladder. BMC Med
Genomics. 3:582010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tijsen AJ, Creemers EE, Moerland PD, de
Windt LJ, van der Wal AC, Kok WE and Pinto YM: MiR423-5p as a
circulating biomarker for heart failure. Circ Res. 106:1035–1039.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Xiao B, Wang Y, Li W, Baker M, Guo J,
Corbet K, Tsalik EL, Li QJ, Palmer SM, Woods CW, et al: Plasma
microRNA signature as a noninvasive biomarker for acute graft
versus host disease. Blood. 122:3365–3375. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hui AB, Lenarduzzi M, Krushel T, Waldron
L, Pintilie M, Shi W, Perez-Ordonez B, Jurisica I, O'Sullivan B,
Waldron J, et al: Comprehensive MicroRNA profiling for head and
neck squamous cell carcinomas. Clin Cancer Res. 16:1129–1139. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Farazi TA, Horlings HM, Ten Hoeve JJ,
Mihailovic A, Halfwerk H, Morozov P, Brown M, Hafner M, Reyal F,
van Kouwenhove M, et al: MicroRNA sequence and expression analysis
in breast tumors by deep sequencing. Cancer Res. 71:4443–4453.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yang H, Cho ME, Li TW, Peng H, Ko KS, Mato
JM and Lu SC: MicroRNAs regulate methionine adenosyltransferase 1A
expression in hepatocellular carcinoma. J Clin Invest. 123:285–298.
2013. View Article : Google Scholar :
|
|
48
|
Fromont G, Rouprêt M, Amira N, Sibony M,
Vallancien G, Validire P and Cussenot O: Tissue microarray analysis
of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and
MSH2 expression in upper urinary tract transitional cell carcinoma.
Eur Urol. 48:764–770. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Nakanishi K, Kawai T, Hiroi S, Kumaki F,
Torikata C, Aurues T and Ikeda T: Expression of telomerase mRNA
component (hTR) in transitional cell carcinoma of the upper urinary
tract. Cancer. 86:2109–2116. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Nakanishi K, Hiroi S, Tominaga S, Aida S,
Kasamatsu H, Matsuyama S, Matsuyama T and Kawai T: Expression of
hypoxia inducible factor-1alpha protein predicts survival in
patients with transitional cell carcinoma of the upper urinary
tract. Clin Cancer Res. 11:2583–2590. 2005. View Article : Google Scholar : PubMed/NCBI
|
